1 study found for:    NCT00818662
Show Display Options
Rank Status Study
1 Completed A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%);   Other: Placebo solution

Indicates status has not been verified in more than two years